Royal Bank of Canada’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21K Buy
2,702
+299
+12% +$2.32K ﹤0.01% 5861
2025
Q1
$13K Sell
2,403
-218
-8% -$1.18K ﹤0.01% 5674
2024
Q4
$16K Buy
2,621
+465
+22% +$2.84K ﹤0.01% 5701
2024
Q3
$22K Buy
2,156
+177
+9% +$1.81K ﹤0.01% 5602
2024
Q2
$26K Buy
1,979
+1,435
+264% +$18.9K ﹤0.01% 5552
2024
Q1
$10K Sell
544
-6,147
-92% -$113K ﹤0.01% 5749
2023
Q4
$63K Buy
6,691
+2,975
+80% +$28K ﹤0.01% 5350
2023
Q3
$41K Buy
3,716
+1,051
+39% +$11.6K ﹤0.01% 5391
2023
Q2
$57K Buy
2,665
+1,085
+69% +$23.2K ﹤0.01% 5264
2023
Q1
$64K Sell
1,580
-1,777
-53% -$72K ﹤0.01% 5101
2022
Q4
$156K Buy
3,357
+2,652
+376% +$123K ﹤0.01% 4634
2022
Q3
$36K Buy
705
+128
+22% +$6.54K ﹤0.01% 5412
2022
Q2
$27K Sell
577
-1,091
-65% -$51.1K ﹤0.01% 5508
2022
Q1
$119K Sell
1,668
-1,988
-54% -$142K ﹤0.01% 5045
2021
Q4
$274K Buy
3,656
+1,236
+51% +$92.6K ﹤0.01% 4518
2021
Q3
$138K Buy
2,420
+1,011
+72% +$57.7K ﹤0.01% 4971
2021
Q2
$62K Buy
1,409
+1,313
+1,368% +$57.8K ﹤0.01% 5402
2021
Q1
$4K Sell
96
-4,928
-98% -$205K ﹤0.01% 6590
2020
Q4
$212K Sell
5,024
-552
-10% -$23.3K ﹤0.01% 4291
2020
Q3
$255K Buy
5,576
+908
+19% +$41.5K ﹤0.01% 3909
2020
Q2
$234K Sell
4,668
-285
-6% -$14.3K ﹤0.01% 3893
2020
Q1
$255K Buy
4,953
+4,861
+5,284% +$250K ﹤0.01% 3694
2019
Q4
$6K Sell
92
-36
-28% -$2.35K ﹤0.01% 5686
2019
Q3
$7K Sell
128
-162
-56% -$8.86K ﹤0.01% 5256
2019
Q2
$24K Hold
290
﹤0.01% 4878
2019
Q1
$28K Hold
290
﹤0.01% 4756
2018
Q4
$21K Sell
290
-54
-16% -$3.91K ﹤0.01% 4837
2018
Q3
$29K Sell
344
-2,230
-87% -$188K ﹤0.01% 4891
2018
Q2
$298K Sell
2,574
-1,606
-38% -$186K ﹤0.01% 3614
2018
Q1
$338K Buy
4,180
+115
+3% +$9.3K ﹤0.01% 3403
2017
Q4
$239K Sell
4,065
-2,368
-37% -$139K ﹤0.01% 3609
2017
Q3
$301K Buy
6,433
+202
+3% +$9.45K ﹤0.01% 3529
2017
Q2
$224K Sell
6,231
-1,189
-16% -$42.7K ﹤0.01% 3608
2017
Q1
$229K Buy
7,420
+6,286
+554% +$194K ﹤0.01% 3648
2016
Q4
$38K Buy
1,134
+720
+174% +$24.1K ﹤0.01% 4668
2016
Q3
$11K Sell
414
-17,831
-98% -$474K ﹤0.01% 4987
2016
Q2
$402K Sell
18,245
-6,774
-27% -$149K ﹤0.01% 3239
2016
Q1
$735K Buy
25,019
+5,659
+29% +$166K ﹤0.01% 2786
2015
Q4
$640K Buy
19,360
+1,496
+8% +$49.5K ﹤0.01% 2914
2015
Q3
$646K Buy
17,864
+563
+3% +$20.4K ﹤0.01% 2745
2015
Q2
$778K Buy
17,301
+3,895
+29% +$175K ﹤0.01% 2726
2015
Q1
$410K Buy
13,406
+6,296
+89% +$193K ﹤0.01% 3257
2014
Q4
$362K Buy
7,110
+6,857
+2,710% +$349K ﹤0.01% 3350
2014
Q3
$10K Buy
253
+3
+1% +$119 ﹤0.01% 4924
2014
Q2
$11K Sell
250
-250
-50% -$11K ﹤0.01% 4863
2014
Q1
$20K Sell
500
-195
-28% -$7.8K ﹤0.01% 4665
2013
Q4
$19K Buy
+695
New +$19K ﹤0.01% 4646